EXELON 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 2 mg/ml SOLUCION ORAL | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 1,5 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA NORMON 1,5 mg CAPSULAS DURAS EFG | Laboratorios Normon, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
PROMETAX 9,5 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA APOTEX 2 mg/ml SOLUCION ORAL EFG | Apotex Europe B.V. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA KERN PHARMA 3 mg CAPSULAS DURAS EFG | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA COMBIX 6 mg CAPSULAS DURAS EFG | Laboratorios Combix, S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA SANDOZ 1,5 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 3 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA NORMON 2 mg/ml SOLUCION ORAL EFG | Laboratorios Normon, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA COMBIX 4,5 mg CAPSULAS DURAS EFG | Laboratorios Combix, S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA KERN PHARMA 1,5 mg CAPSULAS DURAS EFG | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA COMBIX 1,5 mg CAPSULAS DURAS EFG | Laboratorios Combix, S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA SANDOZ 4,5 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 2 mg/ ml SOLUCION ORAL | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA NORMON 4,5 mg CAPSULAS DURAS EFG | Laboratorios Normon, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA KERN PHARMA 4,6 M,G/24 H PARCHES TRANSDERMICOS | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
EXELON 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 4,6 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 4,6 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA KERN PHARMA 6 mg CAPSULAS DURAS EFG | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA COMBIX 3 mg CAPSULAS DURAS EFG | Laboratorios Combix, S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG | Laboratorios Cinfa, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA TEVA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | Teva Pharma S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
EXELON 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA NORMON 3 mg CAPSULAS DURAS EFG | Laboratorios Normon, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
EXELON 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 1,5 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 4,5 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 9,5 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA STADA 9,5 MG/24 H PARCHES TRANSDERMICOS EFG | Laboratorio Stada, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA KERN PHARMA 4,5 mg CAPSULAS DURAS EFG | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
PROMETAX 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA TRAVEL PHARMA 2 mg/ml SOLUCION ORAL EFG | Travel Pharma Company 28, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA NORMON 6 mg CAPSULAS DURAS EFG | Laboratorios Normon, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA TEVA 9,5 MG/24 H PARCHES TRANSDERMICOS EFG | Teva Pharma S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA STADA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | Laboratorio Stada, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA SANDOZ 2 mg/ml SOLUCION ORAL EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA STADA 2mg/ml SOLUCION ORAL EFG | Laboratorio Stada, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA COMBIX 2 mg/ml SOLUCION ORAL EFG | Laboratorios Combix, S.L.U. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
PROMETAX 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
EXELON 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 1,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
PROMETAX 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 3 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA SANDOZ 6 mg CAPSULAS DURAS EFG | Sandoz Farmaceuticals Gmbh | N06DA03 | SI | Diagnóstico Hospitalario | No |
RIVASTIGMINA KERN PHARMA 9,5 MG/24 H PARCHES TRANSDERMICOS | Kern Pharma, S.L. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA VIR 2 mg/ml SOLUCION ORAL EFG | Industria Quimica Y Farmaceutica Vir, S.A. | N06DA03 | SI | Diagnóstico Hospitalario | Si |
RIVASTIGMINA STADA 4,5 mg CAPSULAS DURAS EFG | Laboratorio Stada, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA APOTEX 4,5 mg CAPSULAS DURAS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA STADA 3 mg CAPSULAS DURAS EFG | Laboratorio Stada, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA FARMALIDER 1.5 mg CAPSULAS DURAS EFG | Farmalider, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
TELOMENS 4.5 MG CAPSULAS DURAS EFG | Elpen Pharmaceutical Co Inc | N06DA03 | NO | Diagnóstico Hospitalario | Si |
PROMETAX 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA EDIGEN 2 MG/ML SOLUCION ORAL EFG | Laboratorios Edigen, S.A | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA ORCHID EUROPE LTD 4.5 MG CAPSULAS DURAS EFG | Orchid Europe Limited | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA APOTEX 9.5 MG / 24 H PARCHES TRANSDERMICOS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA APOTEX 6 mg CAPSULAS DURAS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA QUASSET 3 mg CAPSULAS DURAS EFG | Qualitec Europa, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA QUASSET 4,5 mg CAPSULAS DURAS EFG | Qualitec Europa, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
Exelon 13,3 mg/ 24h parche transdermico | Novartis Europharm Ltd. | N06DA03 | NO | Medicamento Sujeto A Prescripción Médica,Diagnóstico Hospitalario | No |
RIVASTIGMINA STADA 6 mg CAPSULAS DURAS EFG | Laboratorio Stada, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA RATIOPHARM 6 mg CAPSULAS DURAS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA ORCHID EUROPE LTD 3.0 MG CAPSULAS DURAS EFG | Orchid Europe Limited | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA WINTHROP 1,5 mg CAPSULAS DURAS EFG | Winthrop Pharma España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
LARO 2 mg/ml SOLUCION ORAL EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA STADA 1,5 mg CAPSULAS DURAS EFG | Laboratorio Stada, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA TECNIGEN 9.5 MG/24 H PARCHES TRANSDERMICOS EFG | Tecnimede España Industria Farmaceutica, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA AUROBINDO 4,5 MG CAPSULAS DURAS EFG | Laboratorios Aurobindo, S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA WINTHROP 3 mg CAPSULAS DURAS EFG | Winthrop Pharma España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
NOFLEBAN 2 mg/ml SOLUCION ORAL EFG | Laboratorios Alter, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
EXELON 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA MONTVEL 2 mg/M SOLUCION ORAL EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA AUROBINDO 1,5 MG CAPSULAS DURAS | Laboratorios Aurobindo, S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
Prometax 13,3mg/24h parche transdermico | Novartis Europharm Ltd. | N06DA03 | NO | Medicamento Sujeto A Prescripción Médica,Diagnóstico Hospitalario | No |
RIVASTIGMINA APOTEX 3 mg CAPSULAS DURAS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA DEPRONAL 6,0 MG CAPSULAS DURAS EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA TIEFENBACHER 2 MG/ML SOLUCION ORAL EFG | Alfred E. Tiefenbacher Gmbh And Co Kg | N06DA03 | NO | Medicamento Sujeto A Prescripción Médica | Si |
RIVASTIGMINA FARMALIDER 4.5 mg CAPSULAS DURAS EFG | Farmalider, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA GALGENICUM 2 mg/ml SOLUCION ORAL EFG | Galenicum Health, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
TELOMENS 6 MG CAPSULAS DURAS EFG | Elpen Pharmaceutical Co Inc | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA DEPRONAL 2 mg/ml SOLUCION ORAL EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA APOTEX 1,5 mg CAPSULAS DURAS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
PROMETAX 3 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA TEVA PHARMA 2 MG/ML SOLUCION ORAL EFG | Teva Pharma S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA APOTEX 4.6 MG / 24 H. PARCHES TRANSDERMICOS EFG | Apotex Europe B.V. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA AUROBINDO 6 MG CAPSULAS DURAS EFG | Laboratorios Aurobindo, S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA RATIOPHARM 4,5 mg CAPSULAS DURAS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA DEPRONAL 4,5 MG CAPSULAS DURAS EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA FARMALIDER 2 mg/ ml SOLUCION ORAL EFG | Farmalider, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA ORCHID EUROPE LTD 6.0 MG CAPSULAS DURAS EFG | Orchid Europe Limited | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA FARMALIDER 6 mg CAPSULAS DURAS EFG | Farmalider, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA RATIOPHARM 1,5 mg CÁPSULAS DURAS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
TELOMENS 1.5 MG CAPSULAS DURAS EFG | Elpen Pharmaceutical Co Inc | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA QUASSET 6 mg CAPSULAS DURAS EFG | Qualitec Europa, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA FARMALIDER 3 mg CAPSULAS DURAS EFG | Farmalider, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA RATIOPHARM 3 mg CAPSULAS DURAS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA TECNIGEN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | Tecnimede España Industria Farmaceutica, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
EXELON 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA AUROBINDO 3 MG CAPSULAS DURAS EFG | Laboratorios Aurobindo, S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA WINTHROP 6 mg CAPSULAS DURAS EFG | Winthrop Pharma España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
PROMETAX 6 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA DEPRONAL 1,5 MG CAPSULAS DURAS EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA DEPRONAL 3,0 MG CAPSULAS DURAS EFG | Vegal Farmacéutica, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA RATIOPHARM 9,5 MG/24H PARCHES TRASDERMICOS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
EXELON 4,5 mg CAPSULAS DURAS | Novartis Europharm Ltd. | N06DA03 | NO | Diagnóstico Hospitalario | No |
RIVASTIGMINA RATIOPHARM 4,6 MG/24 H PARCHES TRASDERMICOS EFG | Ratiopharm España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA WINTHROP 4,5 mg CAPSULAS DURAS EFG | Winthrop Pharma España, S.A. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
TELOMENS 3 MG CAPSULAS DURAS EFG | Elpen Pharmaceutical Co Inc | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA ORCHID EUROPE LTD 1.5 MG CAPSULAS DURAS EFG | Orchid Europe Limited | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA SAG MANUFACTURING 2 mg/ml SOLUCION ORAL EFG | Sag Manufacturing S.L.U. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA QUASSET 1,5 mg CAPSULAS DURAS EFG | Qualitec Europa, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |
RIVASTIGMINA GALENICUM 2 mg/ml SOLUCION ORAL EFG | Galenicum Health, S.L. | N06DA03 | NO | Diagnóstico Hospitalario | Si |